Herrstedt, Jørn

Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial

Adamsen, L., Quist, M., Andersen, C., Moller, T., Herrstedt, J., Kronborg, D., Baadsgaard, M. T., Vistisen, K., Midtgaard, J., Christiansen, B., et al. (2009) · BMJ

Cancer survivorship and careCardiovascular and exercise physiology

Cited by 492

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up

Peterson, D. E., Boers-Doets, C. B., Bensadoun, R. J., & Herrstedt, J. (2015) · Annals of Oncology

Oral health in cancer treatmentOral Health Pathology and Treatment

Cited by 299

Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study.

Harder, S., Groenvold, M., Isaksen, J., Sigaard, J., Frandsen, K. B., Neergaard, M. A., Mondrup, L., & Herrstedt, J. (2019) · Supportive Care in Cancer

Nausea and vomiting managementPain Management and Opioid Use

Cited by 17

Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting

Ruhlmann, C. H., & Herrstedt, J. (2012) · Expert Review of Anticancer Therapy

Nausea and vomiting managementPregnancy and Medication Impact

Cited by 16

Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer

Meteran, H., Knudsen, A. Ø., Jørgensen, T. L., Nielsen, D., & Herrstedt, J. (2024) · Journal of Clinical Medicine

Ovarian cancer diagnosis and treatmentHistone Deacetylase Inhibitors Research

Cited by 12